February 27, 2018

Authors:
Andreas Stolle, Vice President, Process Development Services, API, Patheon, part of Thermo Fisher Scientific
Peter Poechlauer, Ph.D., Innovation Manager, API, Patheon, part of Thermo Fisher Scientific

Innovations in science and technology over the last few decades enable scientists to create far more advanced pharmaceuticals for today’s industry. As a result, patients rightfully expect medication with fewer side effects and physicians anticipate new and better cures for formerly untreatable diseases. Finding a balance between a complex API, its formulation, and its synthesis requires equipment, knowledge, and processes more extensive than those typically required for traditional drug development. It also calls for collaboration across several teams in order to break down the silos that can interrupt the flow of open and clear communication.